By remaining attentive to emerging evidence and addressing these research gaps, the pediatric community can better understand the potential role of GLP-1 receptor agonists in managing pediatric obesity
Clinical considerations regarding the use of obesity pharmacotherapy in adolescents with obesity
Young: Right, so Novo Nordisk essentially sued Hims & Hers because they were saying that, Hey, youre mismarketing your compounded GLP-1s as essentially a first go-to drug instead of our drug. They also were alleging them to be, like, copycats. And these drugs under Novo Nordisk and similarly Eli Lilly, theyre still under patent
Packaging also encourages hospitals to effectively negotiate with manufacturers and suppliers to reduce the purchase price of items and services or to explore alternative group purchasing arrangements, thereby encouraging the most economical health care delivery
The bioavailability is likely lower than injectable forms, but the convenience of oral administration may offset this for some applications
Here, we present an innovative concept in applying in vivo genome editing to treat diseases without a clear genetic underpinning